Published in Genome Res on June 02, 2009
Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet (2010) 10.71
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet (2012) 7.00
SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol (2012) 4.99
Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Genome Res (2010) 2.61
Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum Mol Genet (2013) 1.95
A statistical framework for Illumina DNA methylation arrays. Bioinformatics (2010) 1.92
A subset of methylated CpG sites differentiate psoriatic from normal skin. J Invest Dermatol (2011) 1.73
Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma. BMC Cancer (2011) 1.45
Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet (2010) 1.44
Melanocytes in the skin--comparative whole transcriptome analysis of main skin cell types. PLoS One (2014) 1.44
The DNA methylome. FEBS Lett (2010) 1.38
An atlas of DNA methylomes in porcine adipose and muscle tissues. Nat Commun (2012) 1.28
Double restriction-enzyme digestion improves the coverage and accuracy of genome-wide CpG methylation profiling by reduced representation bisulfite sequencing. BMC Genomics (2013) 1.18
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies. J Transl Med (2010) 1.17
Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. PLoS One (2011) 1.13
Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma. PLoS One (2011) 1.11
DNA-methylation profiling distinguishes malignant melanomas from benign nevi. Pigment Cell Melanoma Res (2011) 1.08
Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma. J Virol (2011) 1.04
Advances in genome-wide DNA methylation analysis. Biotechniques (2010) 1.03
Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats. PLoS One (2012) 0.99
Reduced CTGF expression promotes cell growth, migration, and invasion in nasopharyngeal carcinoma. PLoS One (2013) 0.99
Epigenetic regulation in human melanoma: past and future. Epigenetics (2015) 0.98
Dissecting DNA hypermethylation in cancer. FEBS Lett (2010) 0.98
Removing unwanted variation in a differential methylation analysis of Illumina HumanMethylation450 array data. Nucleic Acids Res (2015) 0.96
Diametrically opposite methylome-transcriptome relationships in high- and low-CpG promoter genes in postmitotic neural rat tissue. Epigenetics (2012) 0.95
Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma. PLoS One (2011) 0.94
Evaluation of right and left ventricular diastolic filling. J Cardiovasc Transl Res (2013) 0.93
KIT is a frequent target for epigenetic silencing in cutaneous melanoma. J Invest Dermatol (2014) 0.91
The hematopoietic stem cell regulatory gene latexin has tumor-suppressive properties in malignant melanoma. J Invest Dermatol (2013) 0.89
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation. J Invest Dermatol (2015) 0.88
Diabetic embryopathy: a role for the epigenome? Birth Defects Res A Clin Mol Teratol (2011) 0.88
methylPipe and compEpiTools: a suite of R packages for the integrative analysis of epigenomics data. BMC Bioinformatics (2015) 0.88
Assessing the efficiency and significance of Methylated DNA Immunoprecipitation (MeDIP) assays in using in vitro methylated genomic DNA. BMC Res Notes (2010) 0.88
Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer. Sci Rep (2015) 0.86
Characterization of DNA methylation and its association with other biological systems in lymphoblastoid cell lines. Genomics (2012) 0.85
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma. Genome Biol (2015) 0.85
Identification of the collagen type 1 α 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma. BMC Cancer (2014) 0.84
Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer. Oncotarget (2016) 0.83
A semantic web framework to integrate cancer omics data with biological knowledge. BMC Bioinformatics (2012) 0.83
Genome-wide mapping reveals conservation of promoter DNA methylation following chicken domestication. Sci Rep (2015) 0.81
Genome-wide methylome analyses reveal novel epigenetic regulation patterns in schizophrenia and bipolar disorder. Biomed Res Int (2015) 0.81
DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features. Pigment Cell Melanoma Res (2014) 0.81
p38δ MAPK: Emerging Roles of a Neglected Isoform. Int J Cell Biol (2014) 0.81
Genome-wide DNA methylation changes between the superficial and deep backfat tissues of the pig. Int J Mol Sci (2012) 0.81
Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma. BMC Med Genomics (2010) 0.80
DNA methylation of alternative promoters directs tissue specific expression of Epac2 isoforms. PLoS One (2013) 0.80
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma. Oncotarget (2016) 0.79
DNA methylation Landscape of body size variation in sheep. Sci Rep (2015) 0.79
Genome-wide screen of DNA methylation changes induced by low dose X-ray radiation in mice. PLoS One (2014) 0.78
Next-generation sequencing: from understanding biology to personalized medicine. Biology (Basel) (2013) 0.78
Constitutional promoter methylation and risk of familial melanoma. Epigenetics (2014) 0.78
DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR. Cell Rep (2016) 0.76
Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma. Proc Natl Acad Sci U S A (2016) 0.76
Combined analysis of DNA methylome and transcriptome reveal novel candidate genes with susceptibility to bovine Staphylococcus aureus subclinical mastitis. Sci Rep (2016) 0.76
Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis. Oncotarget (2016) 0.75
Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance. Ann Transl Med (2015) 0.75
DNA methylation subgroups in melanoma are associated with proliferative and immunological processes. BMC Med Genomics (2015) 0.75
Aberrant promoter methylation profile of Niemann-pick type C1 gene in cardiovascular disease. Iran Biomed J (2013) 0.75
ChARM: Discovery of combinatorial chromatin modification patterns in hepatitis B virus X-transformed mouse liver cancer using association rule mining. BMC Bioinformatics (2016) 0.75
Metallothionein Lower Under-Expression in Benign Tumors than That in Malignant Tumors: Systematic Review Article and Meta-Analysis. Iran J Public Health (2014) 0.75
The DNA methylation landscape of human melanoma. Genomics (2015) 0.75
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities. Clin Epigenetics (2017) 0.75
Bisulfite-independent analysis of CpG island methylation enables genome-scale stratification of single cells. Nucleic Acids Res (2017) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
The epigenomics of cancer. Cell (2007) 30.91
Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29
Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature (2008) 26.78
A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol (2008) 21.72
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet (2007) 20.22
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet (2009) 18.90
Normalization of cDNA microarray data. Methods (2003) 18.69
DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet (2006) 18.08
DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet (2008) 15.45
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet (2005) 15.37
Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol (2009) 11.18
Phenotypic plasticity and the epigenetics of human disease. Nature (2007) 10.37
Methylation-induced repression--belts, braces, and chromatin. Cell (1999) 9.89
Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet (2007) 9.88
The epigenetic progenitor origin of human cancer. Nat Rev Genet (2006) 9.65
Epigenetics: a landscape takes shape. Cell (2007) 8.29
A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol (2002) 7.12
Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet (2004) 5.47
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev (2002) 4.63
Epigenetics and aging: the targets and the marks. Trends Genet (2007) 3.44
The epigenetics of cancer etiology. Semin Cancer Biol (2004) 3.24
An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res (2001) 3.08
The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J Biol Chem (2005) 2.63
Ectopic hypermethylation of flower-specific genes in Arabidopsis. Curr Biol (2000) 2.59
MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. Genome Res (2008) 2.28
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med (2006) 2.16
Relevance of DNA methylation in the management of cancer. Lancet Oncol (2003) 1.97
The small heat shock proteins and their role in human disease. FEBS J (2005) 1.97
Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene (2004) 1.81
Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. PLoS One (2009) 1.80
Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res (2006) 1.73
Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties? Mol Cancer (2008) 1.55
Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res (2006) 1.55
Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood (2008) 1.52
Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Cancer Res (2003) 1.48
Focus on melanoma. Cancer Cell (2002) 1.43
The genome and epigenome of malignant melanoma. APMIS (2007) 1.36
Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. Int J Cancer (2003) 1.25
Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma. Oncogene (2003) 1.21
A population-based validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2005) 1.14
Epigenetic events in malignant melanoma. Pigment Cell Res (2007) 1.10
Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2. Neuro Oncol (2008) 1.07
Identification and investigation of methylated genes in hepatoma. Eur J Cancer (2005) 1.05
Rab33A: characterization, expression, and suppression by epigenetic modification. J Invest Dermatol (2006) 0.98
A methylation-responsive MDBP/RFX site is in the first exon of the collagen alpha2(I) promoter. J Biol Chem (1999) 0.91
Early-stage melanoma: staging criteria and prognostic modeling. Clin Cancer Res (2006) 0.83
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med (2012) 52.99
Human DNA methylomes at base resolution show widespread epigenomic differences. Nature (2009) 34.27
Paired-end mapping reveals extensive structural variation in the human genome. Science (2007) 30.46
Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med (2013) 17.53
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med (2015) 14.71
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature (2011) 13.94
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J Clin Oncol (2014) 9.86
Variation in transcription factor binding among humans. Science (2010) 9.33
Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell (2010) 8.74
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet (2012) 7.00
Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol (2010) 7.00
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. Lancet Oncol (2012) 5.32
In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell (2011) 5.19
Overview of BioCreative II gene normalization. Genome Biol (2008) 5.05
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med (2015) 5.03
High-resolution mapping of DNA copy alterations in human chromosome 22 using high-density tiling oligonucleotide arrays. Proc Natl Acad Sci U S A (2006) 4.84
GeneWays: a system for extracting, analyzing, visualizing, and integrating molecular pathway data. J Biomed Inform (2004) 4.57
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst (2010) 4.57
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells. Pigment Cell Melanoma Res (2010) 4.50
An encyclopedia of mouse DNA elements (Mouse ENCODE). Genome Biol (2012) 4.15
Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol (2002) 4.15
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res (2004) 3.64
GATA-1 binding sites mapped in the beta-globin locus by using mammalian chIp-chip analysis. Proc Natl Acad Sci U S A (2002) 3.41
Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res (2011) 3.36
Systematic prediction and validation of breakpoints associated with copy-number variants in the human genome. Proc Natl Acad Sci U S A (2007) 3.35
A clinical development paradigm for cancer vaccines and related biologics. J Immunother (2007) 2.97
Widespread dynamic DNA methylation in response to biotic stress. Proc Natl Acad Sci U S A (2012) 2.90
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proc Natl Acad Sci U S A (2011) 2.90
Introducing meta-services for biomedical information extraction. Genome Biol (2008) 2.78
Long-term effects of hormone therapy on skin rigidity and wrinkles. Fertil Steril (2005) 2.77
Patterns of population epigenomic diversity. Nature (2013) 2.70
Yale Image Finder (YIF): a new search engine for retrieving biomedical images. Bioinformatics (2008) 2.67
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032. J Transl Med (2010) 2.65
Cadaveric study of breast measurements during augmentation with implants. Plast Reconstr Surg (2015) 2.34
Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLoS Genet (2008) 2.34
MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. Genome Res (2008) 2.28
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg (2012) 2.28
Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors. Cancer Discov (2012) 2.27
Differentiated cells are more efficient than adult stem cells for cloning by somatic cell nuclear transfer. Nat Genet (2006) 2.19
A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood (2009) 2.18
Natural history and surgical management of incidentally discovered low-grade gliomas. J Neurosurg (2011) 2.14
Infantile hemangiomas exhibit neural crest and pericyte markers. Ann Plast Surg (2015) 2.12
Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res (2012) 2.12
The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma. Neurosurgery (2015) 2.06
Advances in the systemic treatment of metastatic melanoma. Oncology (Williston Park) (2013) 2.05
Statistical similarities between transcriptomics and quantitative shotgun proteomics data. Mol Cell Proteomics (2007) 2.05
A genomic analysis of RNA polymerase II modification and chromatin architecture related to 3' end RNA polyadenylation. Genome Res (2008) 2.01
Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies. Semin Oncol (2010) 2.00
Towards semantic role labeling & IE in the medical literature. AMIA Annu Symp Proc (2005) 2.00
MicroRNA signatures differentiate melanoma subtypes. Cell Cycle (2011) 1.99
Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages. PLoS One (2008) 1.91
Recent advances in postoperative pain management. Yale J Biol Med (2010) 1.89
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol (2006) 1.85
Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. PLoS One (2009) 1.80
Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence. Biol Psychiatry (2011) 1.76
A procedure for highly specific, sensitive, and unbiased whole-genome amplification. Proc Natl Acad Sci U S A (2008) 1.73
A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology (2010) 1.71
Temporal transcriptional response to ethylene gas drives growth hormone cross-regulation in Arabidopsis. Elife (2013) 1.64
Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies. Leuk Res (2007) 1.57
A power law global error model for the identification of differentially expressed genes in microarray data. BMC Bioinformatics (2004) 1.56
Extensive genetic variation in somatic human tissues. Proc Natl Acad Sci U S A (2012) 1.56
Two methods for full-length RNA sequencing for low quantities of cells and single cells. Proc Natl Acad Sci U S A (2012) 1.56
Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus. J Invest Dermatol (2012) 1.50
Microarray gene analysis and expression profiles of Dupuytren's contracture. Ann Plast Surg (2003) 1.45
Cadaveric allograft for wound closure after resection of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a report of 32 resections and repairs in 2 patients. Ann Plast Surg (2009) 1.44
Benefits and Risks of Prophylaxis for Deep Venous Thrombosis and Pulmonary Embolus in Plastic Surgery: A Systematic Review and Meta-Analysis of Controlled Trials and Consensus Conference. Plast Reconstr Surg (2016) 1.41
Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer Gene Ther (2003) 1.40
A proposal for the timing of management of patients with melanoma presenting during pregnancy. J Surg Oncol (2012) 1.40
A phase 2 trial of dasatinib in advanced melanoma. Cancer (2010) 1.40
Functional Neck Dissection: The Operative Technique Series. Plast Reconstr Surg (2016) 1.39
Melanoma: a model for testing new agents in combination therapies. J Transl Med (2010) 1.39
Phosphoproteomic screen identifies potential therapeutic targets in melanoma. Mol Cancer Res (2011) 1.38
Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes (2010) 1.35